Your browser doesn't support javascript.
loading
Limited antibody response after BA.4-5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: Results of a case series.
Geisen, Ulf M; Voß, Mathias; Rose, Ruben; Neumann, Franziska; Bäumler, Carina; Müller, Sina; Paltzow, Lea; Christophersen, Christina M; Münier, Merle; Hildebrand, Elena; Hoff, Paula; Longardt, Ann C; Lorentz, Thomas; Schirmer, Jan H; Sümbül, Melike; Tran, Florian; Berner, Dennis; Fickenscher, Helmut; Gerdes, Sascha; Schreiber, Stefan; Krumbholz, Andi; Hoyer, Bimba F.
  • Geisen UM; Medical Department I, Rheumatology, and Clinical Immunology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Voß M; Institute for Infection Medicine, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rose R; Institute for Infection Medicine, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Neumann F; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Bäumler C; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Müller S; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Paltzow L; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Christophersen CM; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Münier M; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Hildebrand E; Medical Department I, Rheumatology, and Clinical Immunology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Hoff P; Department of Rheumatology, Endokrinologikum-Gruppe, Berlin, Germany.
  • Longardt AC; Department of Pediatrics, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Lorentz T; Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany.
  • Schirmer JH; Medical Department I, Rheumatology, and Clinical Immunology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Sümbül M; Department for Dermatology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Tran F; Institute of Clinical Molecular Biology, Christian-Albrecht University of Kiel, Kiel, Germany.
  • Berner D; Department for Internal Medicine I, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus, Kiel.
  • Fickenscher H; Medical Department I, Rheumatology, and Clinical Immunology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Gerdes S; Institute for Infection Medicine, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Schreiber S; Department for Dermatology, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Krumbholz A; Institute for Infection Medicine, Christian-Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Hoyer BF; Institute of Clinical Molecular Biology, Christian-Albrecht University of Kiel, Kiel, Germany.
J Med Virol ; 95(12): e29263, 2023 12.
Article en En | MEDLINE | ID: mdl-38112071
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores del Factor de Necrosis Tumoral / Formación de Anticuerpos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores del Factor de Necrosis Tumoral / Formación de Anticuerpos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article